These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7011731)

  • 1. Internalization of 125I-insulin by IM-9 cultured human lymphocytes: a comparison between A14-monoiodo-pork and biosynthetic human insulin.
    Carpentier JL; Halban PA; Renold AE; Orci L
    Diabetes Care; 1981; 4(2):220-2. PubMed ID: 7011731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor binding of biosynthetic human insulin on isolated pig hepatocytes.
    Gammeltoft S
    Diabetes Care; 1981; 4(2):235-7. PubMed ID: 7011734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptors.
    Keefer LM; Piron MA; De Meyts P
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1391-5. PubMed ID: 7015337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of insulin to rat pancreatic islets: comparison between pancreatic human insulin and biosynthetic human insulin.
    Verspohl EJ; Ammon HP
    Diabetes Care; 1981; 4(2):252-3. PubMed ID: 7011739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding properties and biologic activity in vitro of biosynthetic human insulin.
    Keefer LM; Piron MA; De Meyts P
    Diabetes Care; 1981; 4(2):209-14. PubMed ID: 7011729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency of biosynthetic human insulin determined in vitro.
    Fussgaenger RD; Ditschuneit HH; Martini H; Wiebauer-De Lenardis H; Etzrodt H; Thun C; Ditschuneit H; Pfeiffer EF; Enzmann F
    Diabetes Care; 1981; 4(2):228-34. PubMed ID: 7011733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A14-125I-monoiodoinsulin purified by high performance liquid chromatography (HPLC): cellular receptor binding properties and long-term stability.
    Benzi L; Marchetti P; Cecchetti P; Pezzino V; Gullo D; Masoni A; Navalesi R
    J Nucl Med Allied Sci; 1984; 28(4):277-81. PubMed ID: 6399077
    [No Abstract]   [Full Text] [Related]  

  • 8. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
    Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
    Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
    Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
    J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of biosynthetic human insulin to human antibodies and receptors.
    Petersen KG; Schlüter K; Steinhilber S; Kerp L
    Diabetes Care; 1981; 4(2):248-9. PubMed ID: 7011737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin binding, biologic activity, and metabolism of biosynthetic human insulin.
    Olefsky JM
    Diabetes Care; 1981; 4(2):244-7. PubMed ID: 7011736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of binding of a low affinity, noncooperative insulin [( LeuB25]insulin) to IM-9 lymphocytes.
    Green A; Frank BH; Rubenstein A; Tager H; Olefsky JM
    Endocrinology; 1983 Dec; 113(6):1963-71. PubMed ID: 6357764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polar redistribution of 125I-labelled insulin on the plasma membrane of cultured human lymphocytes.
    Barazzone P; Carpentier JL; Gorden P; Van Obberghen E; Orci L
    Nature; 1980 Jul; 286(5771):401-3. PubMed ID: 6995853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptors: binding kinetics and structure-function relationship of insulin.
    Gammeltoft S
    Physiol Rev; 1984 Oct; 64(4):1321-78. PubMed ID: 6387730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
    Misbin RI; Buynitzky SJ; Almira EC
    Drug Metab Dispos; 1982; 10(2):153-5. PubMed ID: 6124401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O; Linde S; Larsen TR; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of 125I-insulin to specific receptors in IM-9 human lymphocytes. Detection of radioactivity covalently linked to receptors.
    Saviolakis GA; Harrison LC; Roth J
    J Biol Chem; 1981 May; 256(10):4924-8. PubMed ID: 7014566
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of the human insulin receptor.
    Fabry M; Brandenburg D
    Biol Chem Hoppe Seyler; 1992 Sep; 373(9):915-23. PubMed ID: 1466789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the insulin receptor of the cultured human lymphoblastoid cell IM-9. Evidence suggesting that two subunits are required for insulin binding.
    Pollet RJ; Kempner ES; Standaert ML; Haase BA
    J Biol Chem; 1982 Jan; 257(2):894-8. PubMed ID: 7033221
    [No Abstract]   [Full Text] [Related]  

  • 20. Receptor binding and effect of biosynthetic human insulin on 2-deoxyglucose transport.
    Wieringa T; van Putten JP; Van Dijk-Besling M; Krans HM
    Diabetes Care; 1981; 4(2):254-6. PubMed ID: 7011740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.